G. Harbo et al., CANCER OF THE NASAL CAVITY AND PARANASAL SINUSES - A CLINICOPATHOLOGICAL STUDY OF 277 PATIENTS, Acta oncologica, 36(1), 1997, pp. 45-50
In the period 1963-1991, a total of 277 consecutive patients with mali
gnant tumours of the nasal cavity and paranasal sinuses were treated a
t Aarhus University Hospital. The major histological types included sq
uamous cell carcinoma (46%), lymphoma (14%), adenocarcinoma (13%), and
malignant melanoma (9%). Kaplan-Meier estimates of 5-year corrected s
urvival (death from cancer) showed the best prognosis for adenoid cyst
ic carcinoma (87%), adenocarcinoma (65%) and lymphoma (56%), and the p
oorest prognosis for undifferentiated carcinoma (17%) and malignant me
lanoma (24%). The 5-year corrected survival for squamous cell carcinom
a was 35%. Of the 180 patients with treatment failure, the vast majori
ty occurred locally (n = 166); a minor proportion was regional (n = 23
) or distant (n = 30). For the 195 patients with carcinoma, the follow
ing parameters were of statistical prognostic significance (5-year cor
rected survival): histological differentiation (moderate-well 65% vs.
poor 22%), primary T-site (nasal cavity 56% vs. maxillary antrum 39% v
s. other sinuses 24%), tumour stage (T2 68% vs. T3 37% vs. T4 29%), no
dal stage (NO 48% vs. N1-3 21%), treatment (radiotherapy + surgery 56%
vs. radiation alone 35%).